recovery of renal function with resolution of pulmonary oedema. COMMENT In elderly diabetic patients with renal cholesterol atheroembolism, a common precipitant is manipulation of atherosclerotic vessels during vascular surgery or angiography. It can also result from thrombolytic and anticoagulant therapy, sometimes after a considerable delay1. Spontaneous cholesterol embolism is uncommon-found by Cross2 in 1.9% of serial necropsies, always in patients over 60 years of age. The clinical features are varied and make diagnosis difficult. Risk factors for renal cholesterol atheroembolism are advanced age (mean 66 years), hypertension, coronary atherosclerosis and renal impair-ment3. Spontaneous renal atheroembolism often leads to progressive decline in renal function, early dialysisdependence and high mortality3; however, renal function can recover4. Flash pulmonary oedema often points to underlying atheromatous renal artery occlusion, and we suspect that this was present in our patient. Regarding treatment, there is some evidence that a statin can stabilize atherosclerotic plaques, reduce the propensity for atheroembolism and thus preserve renal function5.
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Recurrent spontaneous cholesterol atheroembolism, characterized here by short-lived episodes of acute renal failure and pulmonary oedema, does not seem to have been described previously. This possibility should be considered in any elderly diabetic patient with established atherosclerotic disease who presents with impaired renal function and pulmonary oedema. A spiral computed tomographic (CT) scan of the abdomen with intravenous contrast revealed a vascular lesion in the left lobe of the liver (Figure 1) , and an arteriogram ( Figure 2 ) showed multiple aneurysms of the hepatic arteries and a large false aneurysm from a segmental artery in the left lobe of the liver. To occlude the feeding vessel of the aneurysm, a coil was placed transarterially. A further angiographic study revealed multiple small aneurysms of the splenic and gastroduodenal arteries, a 5 mm aneurysm in the mid pole of the right kidney, and a 2 mm aneurysm in the upper pole of the left kidney. Blood testing showed a persistent acute phase response; she was seronegative for antineutrophilic cytoplasmic antibodies and positive for rheumatoid factor (1 / 1000), anti-DsDNA, and anti-Ro, La, and Sm. C3 complement was 138 mg/dL (< 70), and C4 complement was 19 mg/dL (> 16); there was no evidence of previous infection with hepatitis B.
She was given intravenous methylprednisolone 500 mg on each ofthree consecutive days and the dose of oral prednisolone was increased to 60mg per day. Monthly pulsed cyclophosphamide therapy was then begun, with tapering of the prednisolone to 25 mg per day. After three months offollow-up she remains well and the acute phase response has settled. A follow-up CT scan shows resolution of the false aneurysm. vasculitis has been reported only as a late complication, appearing more than 10 years after the onset of disease5.
One possible explanation for this apparent association is that the initial diagnosis of SLE was erroneous and the clinical features at that stage were due to systemic vasculitis. However, this patient satisfied commonly used criteria for the classification of SLE6 well before presentation with vasculitis. Further possibilities include the development of two unrelated conditions, or a common pathogenic factor causing progression from SLE to systemic vasculitis. The exposure of arterial antigens by SLE-associated tissue damage or the production of anti-endothelial cell antibodies in the context of SLE might account for the progression of the disease in this way.
